Terconazole
Terconazole is a broad-spectrum antifungal medication for the treatment of vaginal yeast infection.
Product Specifications
CAS Number
[67915-31-5]
Product Name Alternative
R42470
UNSPSC
12352005
Hazard Statement
H315, H319, H335, H413
Target
Fungal
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Terconazole.html
Purity
99.93
Solubility
DMSO : ≥ 30 mg/mL
Smiles
CC(N1CCN(C2=CC=C(OC[C@@H]3O[C@@](CN4N=CN=C4)(C5=CC=C(Cl)C=C5Cl)OC3)C=C2)CC1)C
Molecular Formula
C26H31Cl2N5O3
Molecular Weight
532.46
Precautions
H315, H319, H335, H413
References & Citations
[1]Tolman EL, et al. Anticandidal activities of terconazole, a broad-spectrum antimycotic. Antimicrob Agents Chemother. 1986 Jun;29 (6) :986-91.|[2]Van Cutsem J, et al. The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. Am J Obstet Gynecol. 1991 Oct;165 (4 Pt 2) :1200-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1055778-01 1 mg (E-Coli)
Recombinant Caenorhabditis briggsae Cell death abnormality protein 8 (ced-8), partial
Ask
View Details